Artiva Biotherapeutics Inc. (ARTV)
NASDAQ · Healthcare
Artiva Biotherapeutics Inc. Shareholder Equity 2023–2025
Artiva Biotherapeutics Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Artiva Biotherapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 110.0M, a 41.08% decrease year-over-year.
- Artiva Biotherapeutics Inc. shareholder equity for 2025 were 110.0M, a 41.08% decrease from 2024.
- Artiva Biotherapeutics Inc. shareholder equity for 2024 were 186.6M, a 215.20% decrease from 2023.
- Artiva Biotherapeutics Inc. shareholder equity for 2023 were -162.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Artiva Biotherapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $110 |
| 2024 | $187 |
| 2023 | $-162 |
| Artiva Biotherapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $110 |
| 2024-12-31 | $187 |
| 2023-12-31 | $-162 |
Artiva Biotherapeutics Inc. Shareholder Equity — FAQ
Artiva Biotherapeutics Inc. (ARTV) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARTV's shareholder equity history?
The chart and table above show Artiva Biotherapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.